搜索筛选:
搜索耗时4.2459秒,为你在为你在102,285,761篇论文里面共找到 9 篇相符的论文内容
类      型:
[期刊论文] 作者:Robert N.Foley,Peter A.McCullough,, 来源:Journal of Geriatric Cardiology 年份:2005
To this day, the target hemoglobin level that minimizes cardiovascular risk in chronic kidney disease (CKD) patients remains unclear. When one examines the many...
[会议论文] 作者:Robert N.Foley,Bryan M.Curtis,Patrick S.Parfrey, 来源:2013年中国肾性贫血治疗专家共识研讨会 年份:2012
[会议论文] 作者:Robert N.Foley,Bryan M.Curtis,Patrick S.Parfrey, 来源:2013年中国肾性贫血治疗专家共识研讨会 年份:2012
[会议论文] 作者:Robert N.Foley,Bryan M.Curtis,Patrick S.Parfrey, 来源:2013年中国肾性贫血治疗专家共识研讨会 年份:2012
Background and objectives: Optimal hemoglobin targets for chronic kidney disease patients receiving erythropoiesisstimulating agents remain controversial.The effects of different hemoglobin targets on...
[会议论文] 作者:Robert N.Foley,Bryan M.Curtis,Patrick S.Parfrey, 来源:2013年中国肾性贫血治疗专家共识研讨会 年份:2012
Background and objectives: The effects of different hemoglobin targets when using erythropoiesis-stimulating agents on quality of life are somewhat controversial, and predictors of change in quality o...
[会议论文] 作者:James P.Ebben,David T.Gilbertson,Robert N.Foley,Allan J.Collins, 来源:2013年中国肾性贫血治疗专家共识研讨会 年份:2012
National payment policies target a hemoglobin range of 11 to 12.5 g/dl for patients with ESRD.However, clinical complications and provider practices may contribute to wide fluctuations over time.This...
[会议论文] 作者:Patrick S.Parfrey,Robert N.Foley,Barbara H.Wittreich,Martin J.Zagari,Dieter Frei,Daniel J.Sullivan, 来源:2013年中国肾性贫血治疗专家共识研讨会 年份:2012
[会议论文] 作者:JOHN D.HARNETT,ROBERT N.FOLEY,GLORIA M.KENT,PAUL E.BARRE,DAVID MURRAY,PATRICK S.PARFREY, 来源:2013年中国肾性贫血治疗专家共识研讨会 年份:2012
[会议论文] 作者:Patrick S.Parfrey,Robert N.Foley,Barbara H.Wittreich,Daniel J.Sullivan,Martin J.Zagari,Dieter Frei, 来源:2013年中国肾性贫血治疗专家共识研讨会 年份:2012
It is unclear whether physiologic hemoglobin targets lead to cardiac benefit in incident hemodialysis patients without symptomatic heart disease and left ventricular dilation.In this randomized, doubl...
相关搜索: